[Retracted] DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer—A Study Based on TCGA Database

Table 1

Correlation between DNM1 expression and CC clinicopathological features.

Characteristics	Low DNM1 expression	High DNM1 expression
	239	239
Age, (%)			0.402
≤65	102 (21.3%)	92 (19.2%)
>65	137 (28.7%)	147 (30.8%)
Gender, (%)			0.647
Female	116 (24.3%)	110 (23%)
Male	123 (25.7%)	129 (27%)
T stage, (%)			0.540
T1	6 (1.3%)	5 (1%)
T2	46 (9.6%)	37 (7.8%)
T3	160 (33.5%)	163 (34.2%)
T4	26 (5.5%)	34 (7.1%)
N stage, (%)			<0.001
N0	163 (34.1%)	121 (25.3%)
N1	50 (10.5%)	58 (12.1%)
N2	26 (5.4%)	60 (12.6%)
M stage, (%)			0.030
M0	181 (43.6%)	168 (40.5%)
M1	24 (5.8%)	42 (10.1%)
Pathologic stage, (%)			0.002
Stage I	44 (9.4%)	37 (7.9%)
Stage II	108 (23.1%)	79 (16.9%)
Stage III	54 (11.6%)	79 (16.9%)
Stage IV	24 (5.1%)	42 (9%)
Perineural invasion, (%)			0.007
No	77 (42.5%)	58 (32%)
Yes	15 (8.3%)	31 (17.1%)
Lymphatic invasion, (%)			<0.001
No	149 (34.3%)	117 (27%)
Yes	65 (15%)	103 (23.7%)